Erectile Dysfunction is a Marker for Cardiovascular Disease: Results of the Minority Health Institute Expert Advisory Panel
- 1 January 2005
- journal article
- review article
- Published by Oxford University Press (OUP) in The Journal of Sexual Medicine
- Vol. 2 (1) , 40-50
- https://doi.org/10.1111/j.1743-6109.2005.20104_1.x
Abstract
Cardiovascular disease and its related comorbidities are associated with significant morbidity and mortality and affect a disproportionately large number of African Americans and Hispanics. The prevalence of cardiovascular disease is increasing worldwide, which underscores the urgency to improve methods of prevention and early detection. To develop a risk assessment and management algorithm for primary care patients with erectile dysfunction (ED) that facilitates diagnosis, early intervention, and prevention of cardiovascular disease. The Minority Health Institute (MHI) convened an Expert Advisory Panel of cardiologists and urologists to design a new practice model algorithm that uses ED as a clinical tool for early identification of men with systemic vascular disease. A draft of the algorithm was presented at a national symposium and comments from symposium participants were considered in the development of the final algorithm. Erectile dysfunction is common and has long been considered a secondary complication of cardiovascular disease, diabetes, hypertension, and dyslipidemia. However, a growing body of evidence challenges this view, suggesting instead that ED is an early manifestation of atherosclerosis and a precursor to systemic vascular disease. Endothelial dysfunction is the etiologic factor linking ED and cardiovascular disease. The recognition of ED as an early sign of systemic cardiovascular disease offers an opportunity for prevention, particularly in high-risk and underserved minority populations. The MHI algorithm stipulates that all men 25 years old and older regardless of sexual dysfunction complaints should be asked about ED. The presence of ED should prompt an aggressive assessment for cardiovascular risk and occult systemic vascular disease.Keywords
Funding Information
- Minority Health Institute
This publication has 60 references indexed in Scilit:
- Relation of C-reactive protein and other cardiovascular risk factors to penile vascular disease in men with erectile dysfunctionInternational Journal Of Impotence Research, 2003
- Acute and Prolonged Effects of Sildenafil on Brachial Artery Flow-Mediated Dilatation in Type 2 DiabetesDiabetes Care, 2002
- MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trialPublished by Elsevier ,2002
- Oxygen free radicals and the penisExpert Opinion on Pharmacotherapy, 2002
- Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)JAMA, 2001
- Management of sexual dysfunction in patients with cardiovascular disease: recommendations of the Princeton consensus panelThe American Journal of Cardiology, 2000
- Erectile DysfunctionNew England Journal of Medicine, 2000
- Erectile dysfunction in Type 1 and Type 2 diabetics in ItalyInternational Journal of Epidemiology, 2000
- The process of care model for evaluation and treatment of erectile dysfunctionInternational Journal Of Impotence Research, 1999
- The Cavernosal Acetylcholine/Papaverine ResponseInvestigative Radiology, 1990